David Sinclair: GLP-1 Side Effect No One Talks About, AI in His Lab & Reversing Blindness | EP #251

Sinclair co-published the xenohormesis hypothesis with Conrad Howitz about 15–20 years ago. The core idea is that it is not a coincidence that many pharmaceuticals (aspirin, etc.) were derived from plant molecules. Plants, when stressed, upregulate polyphenols that coincidentally activate our own defence pathways. By eating stressed plants, we get a chemical heads-up that hard times may be coming, so the body hunkers down and upregulates survival pathways. This is the basis of why he seeks out colourful, bitter plants. Olive oil fits the same logic: the bitter varieties are full of polyphenols. The practice dovetails with his broader philosophy of avoiding constant abundance.

Sinclair was asked directly about reversing atherosclerosis. He first cited nattokinase as ‘probably the most natural way to do it.’ He acknowledged that getting LDL very low and reducing inflammation can also produce some reversal, and that newer drugs like PCSK9 inhibitors are better than statins. However, he reiterated that he hasn’t seen anything in the literature that matches nattokinase’s potency. The implication is that even in a cardiology landscape dominated by statins and expensive biologics, a traditional fermented soybean enzyme may be superior for plaque regression, a claim that would surprise many clinicians.

Sinclair’s indoor environment advice led him to stress the need to feel temperature swings. He specifically calls out hot sauna as shown to be beneficial. He mentions the venue’s ‘health sauna’ and reveals he has an infrared sauna in his own office. For him, 20–30 minutes is quick and easy, even with a heavy travel schedule. He also includes red light therapy and steam rooms in the same category of environmental stressors that move the body out of a static comfort zone. The protocol is part of a larger manifesto against air‑conditioned monotony.

When asked for tips for centenarians, Sinclair immediately shifted to mindset: the belief you can live longer, that a revolution is coming, and that you are needed in society. He frequently quotes the National Academy of Sciences study showing optimists outlive pessimists by 15%. He doesn’t talk about immortality but about healthspan and reaching ‘longevity escape velocity.’ This stance is consistent with his advocacy for empowerment over fatalism. He also acknowledges his wife’s influence in bringing meditation into his awareness, and he now sees potential biological underpinnings for why mindset might directly alter physiology.

Sinclair admits his indoor environment used to be ‘horrible’ — he drank tap water straight from the faucet. Now, influenced by Serena, the household has HEPA filtration in almost every room, no plastic, no Teflon. He notes a personal improvement: a decades-long nasal drip disappeared. He ties this to the broader abundance/adversity thesis: sealed, sterile, constant-temperature homes with stale air promote a lack of hormetic challenge and increase exposure to synthetic endocrine disruptors. While he doesn’t go into deep mechanistic detail here, the practice aligns with his lab’s interest in inflammation as a driver of aging.

Sinclair references decades of work by endocrinologist Shalender Bhasin, who concluded that testosterone does not extend lifespan but significantly reduces falls — a major cause of late-life decline. He also notes that DHEA can be fixed with a supplement if low. Addressing women’s health, he states the evidence now strongly supports hormone replacement therapy, countering the lingering fear from the Women’s Health Initiative study that was associated with cancer risk. This reflects a broader trend in his advice: separate healthspan (functional living) from lifespan, and don’t shy away from pharmacologic support when the risk/benefit is favourable.

Sinclair acknowledges the overall benefits of GLP-1s (heart, brain beyond weight loss) and says they have paved the social way for longevity medicines, which will be much larger. However, he is concerned about the emerging NAION signal — around 20–30,000 Americans per year are waking up blind. He notes the mechanism is not fully understood and might even be congenital. His lab’s ER100 (OSK-based) therapy has shown reversal of vision loss in animal models for glaucoma and other eye diseases, so Life Biosciences intends to test it against NAION-related blindness as well. This intersects with his broader narrative that rejuvenation therapies could address not only aging but also iatrogenic damage.

Sinclair explains that AI is accelerating their work exponentially — what would have taken hundreds of years now happens in months. One application is AI-driven drug design, screening up to trillions of molecules for the ability to reverse aging, which they have already done. Another is rapid cell-age classification: AI can tell whether a cell is old or young from images in minutes across millions of cells. Moreover, they have collaborated with a group called Cadence, feeding it a lot of transcriptomic data, and the AI made a novel discovery about how to look at biological age that the team hadn’t considered — essentially acting as a creative scientist. He vehemently dismisses the notion that AI merely regurgitates training data, calling it “the biggest bunch of BS.” This signals a fundamental shift in his lab’s methodology.

Sinclair acknowledges the field was hit by a ‘bomb’ a few months ago, as a paper concluded that the genetic influence on lifespan could be as high as 50%. He hedges that the true figure may lie somewhere between 15% and 50%, but the takeaway is that at a minimum, half is still under personal control. He argues that physicians should now routinely perform whole-genome or at least exome sequencing to identify actionable genes, not just traits for ‘fun.’ He is personally working on educating doctors about which genes are important and what can be acted upon. At the same time, he gives a concrete example: his Ashkenazi Jewish genome predisposes his family to stroke and early death (grandmother had a stroke at 30), yet his father has outlived all ancestors by following longevity protocols, demonstrating that even ‘bad’ genetics can be overcome.

Sinclair recounts a conversation with his wife Serena, who argued that often what is derided as metaphysical or ‘woo-woo’ later proves scientifically true. He challenged her with ‘I’m driven by data.’ Then a paper appeared showing that manipulating brain nerves involved in mental thought sends signals all the way to the gut, resulting in increased gut immune cells. That evidence flipped his view. He immediately told Serena he believes it now, and he launched a project with a student named Allegra. She is rejuvenating sensory nerves in the body, and they expect to see broad systemic effects that mirror what meditation practitioners have claimed for thousands of years. He predicts there will be evidence — if not proof — that the mind can overcome matter and cure diseases that medicines cannot. This represents a new frontier for his lab at the intersection of neuroscience, immunology, and longevity.

When asked about indoor air/light quality, Sinclair pivots to a larger critique: humanity has engineered a world of extreme comfort — enough food, chairs, even suitcases with rollers. He calls this ‘abundance mode,’ which is killing us because our bodies evolved to thrive under periodic stress. He recommends intentionally disrupting comfort: sauna (hot, infrared, steam), allowing the body to feel cold or hot, avoiding over-conditioning. He himself installed HEPA filters in almost every room, eliminated plastic and Teflon, drinks filtered water (not straight from tap like he used to), and aims for fresh air and constant movement. He also stresses mental inputs: what you listen to, who you spend time with, what’s on your walls. The prescription is to be ‘selfish’ about all incoming sensory and environmental signals.